HLA-B*58:01 is not the only risk factor associated with allopurinol-induced severe cutaneous adverse drug reactions

مواد مشابهة

• HLA-B(*)58:01 for Allopurinol-Induced Cutaneous Adverse Drug Reactions: Implication for Clinical Interpretation in Thailand
  بواسطة: Sukasem, Chonlaphat, وآخرون
  منشور في: (2016)
• HLA-B*58:01 allele is strongly associated with allopurinol-induced severe cutaneous adverse reactions in a Thai population
  بواسطة: Jantararoungtong, Thawinee, وآخرون
  منشور في: (2014)
• Impact of HLA-B*58:01 allele and allopurinol-induced cutaneous adverse drug reactions: evidence from 21 pharmacogenetic studies
  بواسطة: Wu, Ran, وآخرون
  منشور في: (2016)
• Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study
  بواسطة: Ko, Tai-Ming, وآخرون
  منشور في: (2015)
• Comparison between the HLA-B(∗)58 : 01 Allele and Single-Nucleotide Polymorphisms in Chromosome 6 for Prediction of Allopurinol-Induced Severe Cutaneous Adverse Reactions
  بواسطة: Saksit, Niwat, وآخرون
  منشور في: (2017)